AUSTIN, Texas — Providers should carefully consider the “lipid paradox” when monitoring cardiovascular risks in patients with rheumatic inflammatory diseases, noted a presenter at the 2023 Rheumatology Nurses Society annual conference. According to Kathryn Dao, MD, FACP, FACR, of the University of Texas Southwestern Medical Center, patients with active inflammatory…Read More
Lipid paradox may obscure cardiovascular risk in patients with inflammatory disease
